The present invention relates to novel 3,4-dihydro-1H-pyrimido[1,6-a]pyrimidin-6(2H)-one compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease.
本发明涉及一种新颖的抑制Lp-P
LA2活性的3,4-二
氢-1H-
嘧啶并[1,6-a]
嘧啶-6(2H)-
酮化合物,以及其制备方法、含有它们的组合物,以及它们在治疗与Lp-P
LA2活性相关的疾病中的应用,例如动脉粥样硬化、阿尔茨海默病。